INS and type 1 diabetes mellitus: Thus, this study provides evidence that young patients with T1DM will probably benefit from adjunct therapy with vildagliptin combined with automated insulin delivery, as current AHCL systems often fail to reach target TIR during Ramadan, in particular postprandial TIR targets.